VERACYTE INC's ticker is VCYT and the CUSIP is 92337F107. A total of 126 filers reported holding VERACYTE INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,091,000 | -41.0% | 65,735 | -29.3% | 1.38% | -20.4% |
| Q2 2022 | $1,850,000 | +772.6% | 92,971 | +2050.6% | 1.73% | +1070.3% |
| Q4 2020 | $212,000 | -41.6% | 4,323 | -61.3% | 0.15% | -49.5% |
| Q3 2020 | $363,000 | -47.8% | 11,171 | -58.4% | 0.29% | -58.8% |
| Q2 2020 | $696,000 | -40.4% | 26,855 | -44.1% | 0.71% | -59.6% |
| Q1 2020 | $1,167,000 | -21.9% | 48,024 | -10.3% | 1.76% | +8.4% |
| Q4 2019 | $1,495,000 | -26.7% | 53,540 | -37.0% | 1.63% | -32.0% |
| Q3 2019 | $2,040,000 | -2.0% | 85,000 | +16.4% | 2.39% | +11.2% |
| Q2 2019 | $2,081,000 | -37.5% | 73,000 | -45.1% | 2.15% | -23.3% |
| Q1 2019 | $3,327,000 | +26.0% | 133,000 | -36.7% | 2.81% | +16.0% |
| Q4 2018 | $2,641,000 | -1.2% | 210,000 | -25.0% | 2.42% | +16.1% |
| Q3 2018 | $2,674,000 | +24.5% | 280,000 | +21.7% | 2.08% | +27.2% |
| Q2 2018 | $2,148,000 | – | 230,000 | – | 1.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 119,680 | $2,672 | 2.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 239,571 | $5,349,620 | 1.62% |
| OBERWEIS ASSET MANAGEMENT INC/ | 597,540 | $13,343,068 | 1.42% |
| ARK Investment Management | 7,593,592 | $169,564,898 | 1.30% |
| Capital Impact Advisors, LLC | 32,969 | $736,198 | 1.23% |
| EFG Asset Management (North America) Corp. | 229,837 | $5,127,663 | 1.22% |
| Parkman Healthcare Partners LLC | 225,872 | $5,043,722 | 0.92% |
| Nikko Asset Management Americas, Inc. | 3,173,576 | $70,770,745 | 0.85% |
| Granite Investment Partners, LLC | 865,770 | $19,332,644 | 0.81% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 175,749 | $3,924,475 | 0.64% |